PL3145511T3 - Kompozycja do leczenia oka - Google Patents

Kompozycja do leczenia oka

Info

Publication number
PL3145511T3
PL3145511T3 PL15729760T PL15729760T PL3145511T3 PL 3145511 T3 PL3145511 T3 PL 3145511T3 PL 15729760 T PL15729760 T PL 15729760T PL 15729760 T PL15729760 T PL 15729760T PL 3145511 T3 PL3145511 T3 PL 3145511T3
Authority
PL
Poland
Prior art keywords
eye
treating
composition
Prior art date
Application number
PL15729760T
Other languages
English (en)
Polish (pl)
Inventor
Andreas Bilstein
Hans-Joachim Galla
Mridula DWIVEDI
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53433159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3145511(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bitop Ag filed Critical Bitop Ag
Publication of PL3145511T3 publication Critical patent/PL3145511T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL15729760T 2014-05-22 2015-05-22 Kompozycja do leczenia oka PL3145511T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102014007423.4A DE102014007423A1 (de) 2014-05-22 2014-05-22 Zusammensetzung zur Behandlung des Auges
PCT/EP2015/061434 WO2015177353A1 (de) 2014-05-22 2015-05-22 Zusammensetzung zur behandlung des auges
EP15729760.7A EP3145511B1 (de) 2014-05-22 2015-05-22 Zusammensetzung zur behandlung des auges

Publications (1)

Publication Number Publication Date
PL3145511T3 true PL3145511T3 (pl) 2022-05-02

Family

ID=53433159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15729760T PL3145511T3 (pl) 2014-05-22 2015-05-22 Kompozycja do leczenia oka

Country Status (10)

Country Link
US (3) US20170173012A1 (enExample)
EP (2) EP3977998A1 (enExample)
JP (1) JP2017516770A (enExample)
CN (1) CN106456537A (enExample)
CA (1) CA2949203C (enExample)
DE (1) DE102014007423A1 (enExample)
ES (1) ES2906431T3 (enExample)
PL (1) PL3145511T3 (enExample)
RU (1) RU2016150412A (enExample)
WO (1) WO2015177353A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
DE102016204472A1 (de) * 2016-03-17 2017-09-21 Ursapharm Arzneimittel Gmbh Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition
CN111467349B (zh) * 2020-05-14 2021-06-01 华熙生物科技股份有限公司 人工泪液及其制备方法
CN111991415B (zh) * 2020-09-11 2022-03-01 华熙生物科技股份有限公司 一种眼部护理组合物及其制备方法和用途
US12012238B2 (en) 2021-05-26 2024-06-18 Bausch + Lomb Ireland Limited Packaging solutions
CN116139067B (zh) * 2021-11-22 2024-03-22 华熙生物科技股份有限公司 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383704B2 (ja) * 1993-04-02 2003-03-04 わかもと製薬株式会社 安定なリポソーム水分散液
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
JP3624418B2 (ja) * 1994-12-19 2005-03-02 大正製薬株式会社 リポソーム点眼液
JPH0977656A (ja) * 1995-09-14 1997-03-25 Toshihiro Handa 点眼用エアゾル組成物
GB9716376D0 (en) * 1997-08-01 1997-10-08 Isis Innovation Artificial tear formulation
DE10006578C2 (de) 2000-02-14 2002-10-31 Bitop Ag Verwendung von kompatiblen Soluten als Inhibitoren des enzymatischen Abbaus von makromolekularen Biopolymeren
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
US20080132444A1 (en) * 2004-10-09 2008-06-05 Xiaoling Li Ocular Agent Delivery Systems
DE102006056766A1 (de) 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten
CN101605531B (zh) * 2007-02-09 2012-10-10 爱尔康公司 含有三种聚合物的协同组合的眼用组合物
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
ES2356883B1 (es) * 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
CN101491525A (zh) * 2009-03-03 2009-07-29 山东大学 四氢嘧啶在制备治疗干眼症药物中的应用
EP2823814A1 (en) * 2009-06-10 2015-01-14 Mitotech SA Pharmaceutical composition for use in medical and veterinary ophthalmology
US20110300097A1 (en) * 2010-06-04 2011-12-08 Al-Qahtani Ahmed H Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
DE102011113059A1 (de) * 2011-09-09 2013-03-14 Bitop Ag Therapeutische Anwendungen von Ectoin

Also Published As

Publication number Publication date
WO2015177353A1 (de) 2015-11-26
EP3977998A1 (de) 2022-04-06
CA2949203A1 (en) 2015-11-26
EP3145511A1 (de) 2017-03-29
DE102014007423A1 (de) 2015-11-26
RU2016150412A3 (enExample) 2019-01-17
JP2017516770A (ja) 2017-06-22
US20250195515A1 (en) 2025-06-19
CA2949203C (en) 2023-10-31
ES2906431T3 (es) 2022-04-18
RU2016150412A (ru) 2018-06-25
US20220133719A1 (en) 2022-05-05
US20170173012A1 (en) 2017-06-22
EP3145511B1 (de) 2022-01-05
CN106456537A (zh) 2017-02-22

Similar Documents

Publication Publication Date Title
SG10201707617VA (en) Ophthalmic composition
GB201413037D0 (en) Beyond 10
ZA201703382B (en) Fabric treatment composition
GB201619525D0 (en) Ophthalmic composition
GB201501859D0 (en) Composition
GB201410905D0 (en) Composition
SG11201707117SA (en) Ophthalmic composition
PL3145511T3 (pl) Kompozycja do leczenia oka
GB201403017D0 (en) Composition
GB201414910D0 (en) Composition
GB201403561D0 (en) Composition
GB201414555D0 (en) Composition
GB201410493D0 (en) Composition
PL3446682T3 (pl) Kompozycja okulistyczna
GB201519442D0 (en) Composition
ZA201703701B (en) Ophthalmic composition
IL246919A0 (en) New preparations for the treatment of mechanical nerve injuries
PL3194551T3 (pl) Stała kompozycja do traktowania tekstyliów
GB201420628D0 (en) Composition
GB201415483D0 (en) Composition
GB201404390D0 (en) Composition
GB201403550D0 (en) Composition
GB201402648D0 (en) Composition
IL250781A0 (en) preparation
GB201420400D0 (en) Janus eye